Bill Snyder Archive — Page 94 of 119

April 8, 2015

VU joins national effort to speed Ebola therapy testing

Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.

By Bill Snyder
April 2, 2015

Panel explores real-world impact of health policy research

Humility, persuasion and a good sense of timing are essential for translating health policy research into real world practice that actually improves the health of Americans, according to former Tennessee Governor Phil Bredesen.

By Bill Snyder
April 2, 2015

Pharmacogenomics expert set for Wilkinson Lecture

Mary Relling, Pharm.D., chair of the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology on Thursday, April 9.

By Bill Snyder
March 26, 2015

‘Docking stations’ on chromosomes new anti-cancer target

Vanderbilt University researchers have discovered a cleft in a chromosome-binding protein that may hold the key to stopping most cancers in their tracks.

By Bill Snyder
March 23, 2015

New systems biology method may help improve vaccine evaluation

Researchers at Vanderbilt University have found a new way to “dissect” the human immune response following influenza vaccination.

By Bill Snyder
March 20, 2015

Streptococcus virulence involves three-step plasminogen binding

Researchers at Vanderbilt have shown for the first time how a component of streptococci A and C bacteria helps spread the virus so rapidly through the body.

By Bill Snyder